InSphero Partners with ALPCO to Advance Diabetes Research Schlieren, Switzerland, June 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG, the leading provider of 3D cell-based platforms for preclinical drug safety and efficacy testing, today announced that it is...